Subtype
Liver Carcinoma
CI-CAN-00001073Explore in graph →
783 active trials14 approved drugs17 evidence items
- NCIt
- C7927
Loading cancer entity…
Loading cancer entity…
Subtype
CI-CAN-00001073Explore in graph →
Clinical trials
3,370 studies whose conditions map to this entity or one of its descendants. Status and phase are as posted on ClinicalTrials.gov. 50 studies per page.
Computedformula ci-trial-intel-v1 · interventional studies · entity + NCIt descendants · hover a figure for its formulaCompare cancersTerminated studies (387)
| NCT | Title | Status | Phase | Enrollment (n) | Sponsor | Countries | Last update | Source |
|---|---|---|---|---|---|---|---|---|
| NCT01963429 | Comparison Between Radiofrequency Ablation and Hypofractionated Proton Beam Radiation for Recurrent/Residual HCC | completed | N/A | 144 | National Cancer Center, KoreaOTHER_GOV | 1 | Oct 6, 2020 | clinicaltrials |
| NCT04576572 | Comparison of Criteria for Liver Transplantation in Hepatocellular Carcinoma | completed | — | 424 | Inonu UniversityOTHER | 1 | Oct 6, 2020 | clinicaltrials |
| NCT02519075 | 11C-Choline PET/CT and DWI MRI for Response Assessment of HCC Candidate to TARE | completed | — | 14 | Istituto Clinico HumanitasOTHER | 1 | Oct 1, 2020 | clinicaltrials |
| NCT04568330 | Prevention of Hand-foot Skin Reaction | completed | N/A | 129 | Taipei Veterans General Hospital, TaiwanOTHER_GOV | 0 | Sep 29, 2020 | clinicaltrials |
| NCT02129829 | PROLIFICA - West African Treatment Cohort for Hepatitis B(WATCH) | completed | — | 1,079 | Imperial College LondonOTHER | 2 | Sep 28, 2020 | clinicaltrials |
| NCT04553458 | Factors Affecting Post-treatment Outcomes in Patients With Hepatocellular Carcinoma | completed | — | 407 | Sohag UniversityOTHER | 0 | Sep 17, 2020 | clinicaltrials |
| NCT01938729 | Hepatic Arterial Infusion With Floxuridine and Dexamethasone in Combination With Gemcitabine as Adjuvant Treatment After Resection of Intrahepatic Cholangiocarcinoma | completed | Phase 1 | 8 | Memorial Sloan Kettering Cancer CenterOTHER | 1 | Sep 11, 2020 | clinicaltrials |
| NCT03289533 | A Study Of Avelumab In Combination With Axitinib In Advanced HCC (VEGF Liver 100) | completed | Phase 1 | 22 | PfizerINDUSTRY | 1 | Sep 4, 2020 | clinicaltrials |
| NCT01774344 | Study of Regorafenib After Sorafenib in Patients With Hepatocellular Carcinoma(RESORCE) | completed | Phase 3 | 573 | BayerINDUSTRY | 21 | Aug 20, 2020 | clinicaltrials |
| NCT01935700 | Effect of Colchicine for the Palliative Management of Hepatocellular Carcinoma | completed | Phase 2 | 15 | Kaohsiung Medical University Chung-Ho Memorial HospitalOTHER | 1 | Aug 19, 2020 | clinicaltrials |
| NCT02069145 | Dose Escalation Study of OMP-54F28 in Combination With Sorafenib in Patients With Hepatocellular Cancer | completed | Phase 1 | 10 | OncoMed Pharmaceuticals, Inc.INDUSTRY | 1 | Aug 11, 2020 | clinicaltrials |
| NCT03628651 | Blood Sample Collection to Evaluate Biomarkers for Hepatocellular Carcinoma | completed | — | 2,150 | Exact Sciences CorporationINDUSTRY | 7 | Aug 6, 2020 | clinicaltrials |
| NCT01099631 | IL-2 Expressing, Attenuated Salmonella Typhimurium in Unresectable Hepatic Spread | completed | Phase 1 | 22 | Masonic Cancer Center, University of MinnesotaOTHER | 1 | Jul 20, 2020 | clinicaltrials |
| NCT03140332 | Contribution of the Perfusion Scanner in the Prediction of the Tumor Control of Patients With Hepatocellular Carcinoma Treated With Sorafenib.(HCC-CTPerf) | completed | N/A | 2 | Centre Hospitalier Universitaire, AmiensOTHER | 1 | Jul 20, 2020 | clinicaltrials |
| NCT02560779 | Trial of TRC105 and Sorafenib in Patients With HCC | completed | Phase 1 / Phase 2 | 27 | Tracon Pharmaceuticals Inc.INDUSTRY | 1 | Jul 17, 2020 | clinicaltrials |
| NCT02927626 | Yang Yin Fu Zheng Therapy in HBV Associated Hepatocellular Carcinoma(YYFZTIHBVHCC) | completed | Early Phase 1 | 132 | Beijing Ditan HospitalOTHER | 1 | Jul 10, 2020 | clinicaltrials |
| NCT01871545 | Evaluation of Liver Cancer With Magnetic Resonance Imaging (MRI) | completed | N/A | 84 | Icahn School of Medicine at Mount SinaiOTHER | 1 | Jul 9, 2020 | clinicaltrials |
| NCT02395523 | Hypofractionated Proton Beam Radiotherapy for Inoperable Hepatocellular Carcinoma | completed | N/A | 45 | National Cancer Center, KoreaOTHER_GOV | 1 | Jul 7, 2020 | clinicaltrials |
| NCT02828865 | A Clinical Trial Using Irreversible Electroporation for the Treatment of Liver Cancers | completed | N/A | 18 | National Taiwan University HospitalOTHER | 1 | Jul 7, 2020 | clinicaltrials |
| NCT03267290 | Comparing Diagnostic Accuracy for Liver Tumours Between the Combination of CEUS and CEMRI Versus CECT and CEMRI | completed | N/A | 12 | National Taiwan University HospitalOTHER | 1 | Jul 1, 2020 | clinicaltrials |
| NCT03575806 | Combine TACE and Autologous Tcm Immunotherapy Versus TACE Alone for HCC With MVI After Radical Resection | completed | Phase 2 | 52 | Cancer Institute and Hospital, Chinese Academy of Medical SciencesOTHER | 1 | Jun 11, 2020 | clinicaltrials |
| NCT04415567 | Adjuvant Lenvatinib Prevents Recurrence of High-risk Patients With HBV-related HCC After Liver Transplantation | completed | — | 23 | Jinyang GuOTHER | 1 | Jun 4, 2020 | clinicaltrials |
| NCT04412161 | Liver Transplant for Larger Hepatocellular Carcinoma in Malatya: The Role of GGT and AFP | completed | — | 50 | Inonu UniversityOTHER | 0 | Jun 2, 2020 | clinicaltrials |
| NCT00913757 | A Study of Molecular and Genetic Factors for Liver Cancer in the Greater Baltimore Area | completed | — | 1,871 | National Cancer Institute (NCI)NIH | 1 | May 4, 2020 | clinicaltrials |
| NCT02834546 | Correlation Between Sorafenib Plasma Concentrations, Toxicity and Disease Control Rate in Patients Treated by Sorafenib for Hepatocellular Carcinoma(ACTES) | completed | — | 143 | University Hospital, BordeauxOTHER | 1 | Apr 29, 2020 | clinicaltrials |
| NCT01775501 | Sorafenib + mFOLFOX for Hepatocellular Carcinoma | completed | Phase 2 | 40 | Massachusetts General HospitalOTHER | 1 | Apr 22, 2020 | clinicaltrials |
| NCT02716766 | Study of SECOX Versus Sorafenib as First-Line Treatment in Patients With Advanced Hepatocellular Carcinoma (HCC) | completed | Phase 2 | 46 | The University of Hong KongOTHER | 1 | Apr 10, 2020 | clinicaltrials |
| NCT03578874 | SECOX as Neoadjuvant Therapy in Patients With Locally Advanced HCC | completed | Phase 2 | 15 | The University of Hong KongOTHER | 1 | Apr 9, 2020 | clinicaltrials |
| NCT03806218 | Bipolar RFA Using Twin ICW Electrodes vs. Switching Monopolar RFA for Recurrent HCC | completed | N/A | 77 | Seoul National University HospitalOTHER | 1 | Apr 7, 2020 | clinicaltrials |
| NCT03594188 | Effects of Anesthetic Methods on Hepatic Cancer Cell Malignancy | completed | N/A | 24 | RenJi HospitalOTHER | 1 | Apr 6, 2020 | clinicaltrials |
| NCT01507168 | A Study of GC33 (RO5137382) in Patients With Advanced or Metastatic Hepatocellular Carcinoma | completed | Phase 2 | 185 | Hoffmann-La RocheINDUSTRY | 13 | Apr 3, 2020 | clinicaltrials |
| NCT02358070 | Epidemiologic Study of Hepatocellular Carcinoma in the US | completed | — | 45 | Stanford UniversityOTHER | 1 | Mar 24, 2020 | clinicaltrials |
| NCT03699657 | Dual and Single Switching Monopolar RFA Using Separable Clustered Electrode for Treatment of HCC | completed | N/A | 86 | Seoul National University HospitalOTHER | 1 | Mar 20, 2020 | clinicaltrials |
| NCT01347333 | Stereotactic Body Radiotherapy for Liver Tumors | completed | N/A | 23 | Mercy ResearchOTHER | 1 | Mar 3, 2020 | clinicaltrials |
| NCT04266548 | Arterial Base Fluorescence Segmental Positive Staining | completed | N/A | 8 | Chang Gung Memorial HospitalOTHER | 1 | Feb 12, 2020 | clinicaltrials |
| NCT01833299 | Transcatheter Arterial Chemoembolization Combined With Sorafenib for Unresectable Hepatocellular Carcinoma | completed | Phase 3 | 120 | Sun Yat-sen UniversityOTHER | 1 | Feb 11, 2020 | clinicaltrials |
| NCT02240433 | A Study of LY2157299 in Participants With Unresectable Hepatocellular Cancer (HCC) | completed | Phase 1 | 9 | Eli Lilly and CompanyINDUSTRY | 1 | Feb 5, 2020 | clinicaltrials |
| NCT03203005 | IMA970A Plus CV8102 in Very Early, Early and Intermediate Stage Hepatocellular Carcinoma Patients | completed | Phase 1 / Phase 2 | 22 | National Cancer Institute, NaplesOTHER | 5 | Feb 5, 2020 | clinicaltrials |
| NCT03804593 | HCCBloodTest for Detection of Hepatocellular Carcinoma (HCC) | completed | — | 175 | Epigenomics, IncINDUSTRY | 1 | Jan 30, 2020 | clinicaltrials |
| NCT02548780 | LifePearl-Doxo Pharmacokinetic (PK) Study | completed | N/A | 15 | Terumo Europe N.V.INDUSTRY | 3 | Jan 27, 2020 | clinicaltrials |
| NCT03053596 | LifePearl Anthracyclin Registry in Selective Chemo-Embolization of Patients With Unresectable HCC (PARIS Registry) | completed | — | 102 | Terumo Europe N.V.INDUSTRY | 2 | Jan 27, 2020 | clinicaltrials |
| NCT02409524 | An Individualized Anti-Cancer Vaccine in Advanced Hepatocellular Carcinoma Subjects | completed | Phase 2 | 15 | Mirror Biologics, Inc.INDUSTRY | 1 | Jan 22, 2020 | clinicaltrials |
| NCT00341705 | The Second Multicenter Hemophilia Cohort Study | completed | — | 2,565 | National Cancer Institute (NCI)NIH | 8 | Dec 17, 2019 | clinicaltrials |
| NCT00825877 | Long-term Follow-up of HALT-C Sustained Virological Responders | completed | — | 140 | National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)NIH | 1 | Dec 17, 2019 | clinicaltrials |
| NCT02730611 | Metabolic Syndrome, Bile Acids, Hepatocellular Carcinoma and Cholangiocarcinoma(METSLIVER) | completed | — | 124 | Assistance Publique - Hôpitaux de ParisOTHER | 1 | Dec 17, 2019 | clinicaltrials |
| NCT01334112 | Study of Axitinib in Patients With Unresectable Hepatocellular Carcinoma(AXITINIB) | completed | Phase 2 | 30 | University Health Network, TorontoOTHER | 1 | Dec 12, 2019 | clinicaltrials |
| NCT01853618 | Tremelimumab With Chemoembolization or Ablation for Liver Cancer | completed | Phase 1 / Phase 2 | 61 | National Cancer Institute (NCI)NIH | 1 | Dec 10, 2019 | clinicaltrials |
| NCT02774187 | Sorafenib Alone Versus Sorafenib Combined With HAIC for Advanced HCC | completed | Phase 3 | 247 | Sun Yat-sen UniversityOTHER | 1 | Dec 5, 2019 | clinicaltrials |
| NCT00908752 | Phase III Trans-Arterial Chemo-Embolization (TACE) Adjuvant HCC(BRISK TA) | completed | Phase 3 | 734 | Bristol-Myers SquibbINDUSTRY | 13 | Dec 2, 2019 | clinicaltrials |
| NCT02643173 | Hepatocellular Carcinoma Recurrence and Anesthesia | completed | — | 259 | Seoul National University Bundang HospitalOTHER | 1 | Nov 22, 2019 | clinicaltrials |
Data updated 23 days agoSource updated Oct 6, 2020source: clinicaltrials